139 related articles for article (PubMed ID: 10201966)
1. Contribution of renal secreted complement C3 to the circulating pool in humans.
Tang S; Zhou W; Sheerin NS; Vaughan RW; Sacks SH
J Immunol; 1999 Apr; 162(7):4336-41. PubMed ID: 10201966
[TBL] [Abstract][Full Text] [Related]
2. Extrahepatic secreted complement C3 contributes to circulating C3 levels in humans.
Naughton MA; Botto M; Carter MJ; Alexander GJ; Goldman JM; Walport MJ
J Immunol; 1996 Apr; 156(8):3051-6. PubMed ID: 8609428
[TBL] [Abstract][Full Text] [Related]
3. C3 polymorphisms and allograft outcome in renal transplantation.
Varagunam M; Yaqoob MM; Döhler B; Opelz G
N Engl J Med; 2009 Feb; 360(9):874-80. PubMed ID: 19246358
[TBL] [Abstract][Full Text] [Related]
4. Complement component C3 allotypes and outcomes in liver transplantation.
Dhillon N; Walsh L; Krüger B; Mehrotra A; Ward SC; Godbold J; Radwan M; Schiano T; Murphy B; Schröppel B
Liver Transpl; 2010 Feb; 16(2):198-203. PubMed ID: 20104494
[TBL] [Abstract][Full Text] [Related]
5. Complement C3 gene polymorphism in renal transplantation (an Iranian experience).
Bazyar N; Azarpira N; Khatami SR; Galehdari H; Salahi H
Gene; 2012 May; 498(2):254-8. PubMed ID: 22361228
[TBL] [Abstract][Full Text] [Related]
6. Anti-glutathione S-transferase T1 antibody-mediated rejection in C4d-positive renal allograft recipients.
Aguilera I; Alvarez-Marquez A; Gentil MA; Fernandez-Alonso J; Fijo J; Saez C; Wichmann I; Nuñez-Roldan A
Nephrol Dial Transplant; 2008 Jul; 23(7):2393-8. PubMed ID: 18308775
[TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of C3 allotypes related to transplant outcome in human renal allografts.
Andrews PA; Finn JE; Mathieson PW; Sacks SH
Transplantation; 1995 Dec; 60(11):1342-6. PubMed ID: 8525532
[TBL] [Abstract][Full Text] [Related]
8. Local renal complement C3 induction by donor brain death is associated with reduced renal allograft function after transplantation.
Damman J; Nijboer WN; Schuurs TA; Leuvenink HG; Morariu AM; Tullius SG; van Goor H; Ploeg RJ; Seelen MA
Nephrol Dial Transplant; 2011 Jul; 26(7):2345-54. PubMed ID: 21127132
[TBL] [Abstract][Full Text] [Related]
9. Complement activation in early protocol kidney graft biopsies after living-donor transplantation.
Sund S; Hovig T; Reisaeter AV; Scott H; Bentdal Ø; Mollnes TE
Transplantation; 2003 Apr; 75(8):1204-13. PubMed ID: 12717204
[TBL] [Abstract][Full Text] [Related]
10. Use of PCR and PCR-SSP for detection of urinary donor-origin DNA in renal transplant recipients with acute rejection.
Zhang Z; Ohkohchi N; Okazaki H; Guo Y
Chin Med J (Engl); 2003 Feb; 116(2):191-4. PubMed ID: 12775227
[TBL] [Abstract][Full Text] [Related]
11. Association of complement C3 gene variants with renal transplant outcome of deceased cardiac dead donor kidneys.
Damman J; Daha MR; Leuvenink HG; van Goor H; Hillebrands JL; Dijk MC; Hepkema BG; Snieder H; Born Jv; de Borst MH; Bakker SJ; Navis GJ; Ploeg RJ; Seelen MA
Am J Transplant; 2012 Mar; 12(3):660-8. PubMed ID: 22176838
[TBL] [Abstract][Full Text] [Related]
12. The UNOS Scientific Renal Transplant Registry.
Cecka JM
Clin Transpl; 1999; ():1-21. PubMed ID: 11038622
[TBL] [Abstract][Full Text] [Related]
13. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
14. Influence of donor C3 allotype on late renal-transplantation outcome.
Brown KM; Kondeatis E; Vaughan RW; Kon SP; Farmer CK; Taylor JD; He X; Johnston A; Horsfield C; Janssen BJ; Gros P; Zhou W; Sacks SH; Sheerin NS
N Engl J Med; 2006 May; 354(19):2014-23. PubMed ID: 16687714
[TBL] [Abstract][Full Text] [Related]
15. The UNOS renal transplant registry.
Cecka JM
Clin Transpl; 2001; ():1-18. PubMed ID: 12211771
[TBL] [Abstract][Full Text] [Related]
16. Organ-specific contribution to circulating C7 levels by the bone marrow and liver in humans.
Naughton MA; Walport MJ; Würzner R; Carter MJ; Alexander GJ; Goldman JM; Botto M
Eur J Immunol; 1996 Sep; 26(9):2108-12. PubMed ID: 8814254
[TBL] [Abstract][Full Text] [Related]
17. Expression and tissue localization of donor-specific complement C3 synthesized in human renal allografts.
Andrews PA; Finn JE; Lloyd CM; Zhou W; Mathieson PW; Sacks SH
Eur J Immunol; 1995 Apr; 25(4):1087-93. PubMed ID: 7737278
[TBL] [Abstract][Full Text] [Related]
18. Blood group Lewis alloantibodies cause antibody-mediated rejection in renal transplant recipients.
Boratyńska M; Banasik M; Hałoń A; Patrzałek D; Klinger M
Transplant Proc; 2007 Nov; 39(9):2711-4. PubMed ID: 18021965
[TBL] [Abstract][Full Text] [Related]
19. Plasma levels of soluble CD30 in kidney graft recipients as predictors of acute allograft rejection.
Ayed K; Abdallah TB; Bardi R; Abderrahim E; Kheder A
Transplant Proc; 2006 Sep; 38(7):2300-2. PubMed ID: 16980071
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppression in live-related donor renal transplantation.
Iman A; Rao M; Juneja R; Jacob CK
Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
